Skip to main content
. 2017 Jan 1;11(1):30–36.

Figure 1.

Figure 1

Duration of first- (imatinib) and second-generation (dasatinib and nilotinib) therapy per patient before HSCT. Patients are identified numerically, respecting the chronological order in which treatment started from 2002 to 2013, with patient 1 being the first and patient 21 last patient